NASDAQ:BRNS Stock Quote

Barinthus Biotherapeutics plc is a biopharmaceutical company focused on the discovery and development of innovative therapies aimed at treating a range of serious diseases

The company utilizes advanced biotechnological approaches to create novel drug candidates that target underlying mechanisms of illness. With a commitment to enhancing patient outcomes, Barinthus Biotherapeutics emphasizes research and development to deliver effective and safe treatments, advancing the field of medicine and addressing unmet medical needs.